The federal government has been releasing a number of policies and proposals that will affect care delivery and are aimed at rising costs of care and prescription drugs.
Ted Okon, executive director of the Community Oncology Alliance (COA), sat down with Managed Care Cast to discuss a number of policies affecting COA’s members, including proposals around chimeric antigen receptor T-cell therapies, pharmacy benefit managers, and the Oncology Care Model.
Read more about the stories in this podcast:
CMS Proposes That Patients Be Enrolled in Studies to Get Coverage for CAR T-Cell Therapy: https://www.ajmc.com/newsroom/cms-proposes-that-patients-be-enrolled-in-studies-to-get-coverage-for-car-tcell-therapy
Ted Okon on Policy Priorities for COA in 2019: https://www.ajmc.com/conferences/coapayersummit2018/ted-okon-on-policy-priorities-for-coa-in-2019
COA's OCM 2.0: Moving Toward a Universal Payment Model: https://www.ajmc.com/conferences/coapayersummit2018/coas-ocm-20-moving-toward-a-universal-payment-model
More Than 300 Groups Seek Halt to CMS' Plans for Global Drug Pricing Index: https://www.ajmc.com/newsroom/more-than-300-groups-seek-halt-to-cms-plans-for-global-drug-pricing-index
Trump Proposes Allowing Medicare to Base Drug Prices on What Other Countries Pay: https://www.ajmc.com/newsroom/trump-proposes-allowing-medicare-to-base-drug-prices-on-what-other-countries-pay
HHS Proposes to End Drug Rebates in Medicare, Medicaid Managed Care: https://www.ajmc.com/newsroom/hhs-proposes-to-end-drug-rebates-in-medicare-medicaid-managed-care
